[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global RNA-interference (RNAi) Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

March 2023 | 110 pages | ID: GCD7C05850EAEN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

RNA interference is a biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. Historically, RNAi was known by other names, including co-suppression, post-transcriptional gene silencing, and quelling.

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the RNA-interference (RNAi) market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global RNA-interference (RNAi) market are covered in Chapter 9:
Tekmira Pharmaceuticals Corporation
Phio Pharmaceuticals Corp.
Quark Pharmaceuticals Inc.
Thermo Fisher Scientific Inc.
Ionis Pharmaceuticals Inc.
RXI Pharmaceuticals
Arcturus Therapeutics
Silence Therapeutics PLC
Merck & Co. Inc. (Sigma Aldrich)
Dicerna Pharmaceuticals
Benitec Biopharma Ltd
Arrowhead
ISIS Pharmaceuticals
Qiagen NV
Alnylam Pharmaceuticals

In Chapter 5 and Chapter 7.3, based on types, the RNA-interference (RNAi) market from 2017 to 2027 is primarily split into:
Chemical synthesis
In vitro transcription
In vivo expression

In Chapter 6 and Chapter 7.4, based on applications, the RNA-interference (RNAi) market from 2017 to 2027 covers:
Drug Discovery and Development
Therapeutics

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa

Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the RNA-interference (RNAi) market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the RNA-interference (RNAi) Industry.

2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.

3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 RNA-INTERFERENCE (RNAI) MARKET OVERVIEW

1.1 Product Overview and Scope of RNA-interference (RNAi) Market
1.2 RNA-interference (RNAi) Market Segment by Type
  1.2.1 Global RNA-interference (RNAi) Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global RNA-interference (RNAi) Market Segment by Application
  1.3.1 RNA-interference (RNAi) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global RNA-interference (RNAi) Market, Region Wise (2017-2027)
  1.4.1 Global RNA-interference (RNAi) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States RNA-interference (RNAi) Market Status and Prospect (2017-2027)
  1.4.3 Europe RNA-interference (RNAi) Market Status and Prospect (2017-2027)
  1.4.4 China RNA-interference (RNAi) Market Status and Prospect (2017-2027)
  1.4.5 Japan RNA-interference (RNAi) Market Status and Prospect (2017-2027)
  1.4.6 India RNA-interference (RNAi) Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia RNA-interference (RNAi) Market Status and Prospect (2017-2027)
  1.4.8 Latin America RNA-interference (RNAi) Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa RNA-interference (RNAi) Market Status and Prospect (2017-2027)
1.5 Global Market Size of RNA-interference (RNAi) (2017-2027)
  1.5.1 Global RNA-interference (RNAi) Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global RNA-interference (RNAi) Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the RNA-interference (RNAi) Market

2 INDUSTRY OUTLOOK

2.1 RNA-interference (RNAi) Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 RNA-interference (RNAi) Market Drivers Analysis
2.4 RNA-interference (RNAi) Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 RNA-interference (RNAi) Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on RNA-interference (RNAi) Industry Development

3 GLOBAL RNA-INTERFERENCE (RNAI) MARKET LANDSCAPE BY PLAYER

3.1 Global RNA-interference (RNAi) Sales Volume and Share by Player (2017-2022)
3.2 Global RNA-interference (RNAi) Revenue and Market Share by Player (2017-2022)
3.3 Global RNA-interference (RNAi) Average Price by Player (2017-2022)
3.4 Global RNA-interference (RNAi) Gross Margin by Player (2017-2022)
3.5 RNA-interference (RNAi) Market Competitive Situation and Trends
  3.5.1 RNA-interference (RNAi) Market Concentration Rate
  3.5.2 RNA-interference (RNAi) Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL RNA-INTERFERENCE (RNAI) SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global RNA-interference (RNAi) Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global RNA-interference (RNAi) Revenue and Market Share, Region Wise (2017-2022)
4.3 Global RNA-interference (RNAi) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States RNA-interference (RNAi) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States RNA-interference (RNAi) Market Under COVID-19
4.5 Europe RNA-interference (RNAi) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe RNA-interference (RNAi) Market Under COVID-19
4.6 China RNA-interference (RNAi) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China RNA-interference (RNAi) Market Under COVID-19
4.7 Japan RNA-interference (RNAi) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan RNA-interference (RNAi) Market Under COVID-19
4.8 India RNA-interference (RNAi) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India RNA-interference (RNAi) Market Under COVID-19
4.9 Southeast Asia RNA-interference (RNAi) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia RNA-interference (RNAi) Market Under COVID-19
4.10 Latin America RNA-interference (RNAi) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America RNA-interference (RNAi) Market Under COVID-19
4.11 Middle East and Africa RNA-interference (RNAi) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa RNA-interference (RNAi) Market Under COVID-19

5 GLOBAL RNA-INTERFERENCE (RNAI) SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global RNA-interference (RNAi) Sales Volume and Market Share by Type (2017-2022)
5.2 Global RNA-interference (RNAi) Revenue and Market Share by Type (2017-2022)
5.3 Global RNA-interference (RNAi) Price by Type (2017-2022)
5.4 Global RNA-interference (RNAi) Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global RNA-interference (RNAi) Sales Volume, Revenue and Growth Rate of Chemical synthesis (2017-2022)
  5.4.2 Global RNA-interference (RNAi) Sales Volume, Revenue and Growth Rate of In vitro transcription (2017-2022)
  5.4.3 Global RNA-interference (RNAi) Sales Volume, Revenue and Growth Rate of In vivo expression (2017-2022)

6 GLOBAL RNA-INTERFERENCE (RNAI) MARKET ANALYSIS BY APPLICATION

6.1 Global RNA-interference (RNAi) Consumption and Market Share by Application (2017-2022)
6.2 Global RNA-interference (RNAi) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global RNA-interference (RNAi) Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global RNA-interference (RNAi) Consumption and Growth Rate of Drug Discovery and Development (2017-2022)
  6.3.2 Global RNA-interference (RNAi) Consumption and Growth Rate of Therapeutics (2017-2022)

7 GLOBAL RNA-INTERFERENCE (RNAI) MARKET FORECAST (2022-2027)

7.1 Global RNA-interference (RNAi) Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global RNA-interference (RNAi) Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global RNA-interference (RNAi) Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global RNA-interference (RNAi) Price and Trend Forecast (2022-2027)
7.2 Global RNA-interference (RNAi) Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States RNA-interference (RNAi) Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe RNA-interference (RNAi) Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China RNA-interference (RNAi) Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan RNA-interference (RNAi) Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India RNA-interference (RNAi) Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia RNA-interference (RNAi) Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America RNA-interference (RNAi) Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa RNA-interference (RNAi) Sales Volume and Revenue Forecast (2022-2027)
7.3 Global RNA-interference (RNAi) Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global RNA-interference (RNAi) Revenue and Growth Rate of Chemical synthesis (2022-2027)
  7.3.2 Global RNA-interference (RNAi) Revenue and Growth Rate of In vitro transcription (2022-2027)
  7.3.3 Global RNA-interference (RNAi) Revenue and Growth Rate of In vivo expression (2022-2027)
7.4 Global RNA-interference (RNAi) Consumption Forecast by Application (2022-2027)
  7.4.1 Global RNA-interference (RNAi) Consumption Value and Growth Rate of Drug Discovery and Development(2022-2027)
  7.4.2 Global RNA-interference (RNAi) Consumption Value and Growth Rate of Therapeutics(2022-2027)
7.5 RNA-interference (RNAi) Market Forecast Under COVID-19

8 RNA-INTERFERENCE (RNAI) MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 RNA-interference (RNAi) Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of RNA-interference (RNAi) Analysis
8.6 Major Downstream Buyers of RNA-interference (RNAi) Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the RNA-interference (RNAi) Industry

9 PLAYERS PROFILES

9.1 Tekmira Pharmaceuticals Corporation
  9.1.1 Tekmira Pharmaceuticals Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.1.3 Tekmira Pharmaceuticals Corporation Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Phio Pharmaceuticals Corp.
  9.2.1 Phio Pharmaceuticals Corp. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.2.3 Phio Pharmaceuticals Corp. Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Quark Pharmaceuticals Inc.
  9.3.1 Quark Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.3.3 Quark Pharmaceuticals Inc. Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Thermo Fisher Scientific Inc.
  9.4.1 Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.4.3 Thermo Fisher Scientific Inc. Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Ionis Pharmaceuticals Inc.
  9.5.1 Ionis Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.5.3 Ionis Pharmaceuticals Inc. Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 RXI Pharmaceuticals
  9.6.1 RXI Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.6.3 RXI Pharmaceuticals Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Arcturus Therapeutics
  9.7.1 Arcturus Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.7.3 Arcturus Therapeutics Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Silence Therapeutics PLC
  9.8.1 Silence Therapeutics PLC Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.8.3 Silence Therapeutics PLC Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Merck & Co. Inc. (Sigma Aldrich)
  9.9.1 Merck & Co. Inc. (Sigma Aldrich) Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.9.3 Merck & Co. Inc. (Sigma Aldrich) Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Dicerna Pharmaceuticals
  9.10.1 Dicerna Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.10.3 Dicerna Pharmaceuticals Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Benitec Biopharma Ltd
  9.11.1 Benitec Biopharma Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.11.3 Benitec Biopharma Ltd Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 Arrowhead
  9.12.1 Arrowhead Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.12.3 Arrowhead Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis
9.13 ISIS Pharmaceuticals
  9.13.1 ISIS Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.13.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.13.3 ISIS Pharmaceuticals Market Performance (2017-2022)
  9.13.4 Recent Development
  9.13.5 SWOT Analysis
9.14 Qiagen NV
  9.14.1 Qiagen NV Basic Information, Manufacturing Base, Sales Region and Competitors
  9.14.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.14.3 Qiagen NV Market Performance (2017-2022)
  9.14.4 Recent Development
  9.14.5 SWOT Analysis
9.15 Alnylam Pharmaceuticals
  9.15.1 Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.15.2 RNA-interference (RNAi) Product Profiles, Application and Specification
  9.15.3 Alnylam Pharmaceuticals Market Performance (2017-2022)
  9.15.4 Recent Development
  9.15.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES

Figure RNA-interference (RNAi) Product Picture
Table Global RNA-interference (RNAi) Market Sales Volume and CAGR (%) Comparison by Type
Table RNA-interference (RNAi) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global RNA-interference (RNAi) Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global RNA-interference (RNAi) Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on RNA-interference (RNAi) Industry Development
Table Global RNA-interference (RNAi) Sales Volume by Player (2017-2022)
Table Global RNA-interference (RNAi) Sales Volume Share by Player (2017-2022)
Figure Global RNA-interference (RNAi) Sales Volume Share by Player in 2021
Table RNA-interference (RNAi) Revenue (Million USD) by Player (2017-2022)
Table RNA-interference (RNAi) Revenue Market Share by Player (2017-2022)
Table RNA-interference (RNAi) Price by Player (2017-2022)
Table RNA-interference (RNAi) Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global RNA-interference (RNAi) Sales Volume, Region Wise (2017-2022)
Table Global RNA-interference (RNAi) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global RNA-interference (RNAi) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global RNA-interference (RNAi) Sales Volume Market Share, Region Wise in 2021
Table Global RNA-interference (RNAi) Revenue (Million USD), Region Wise (2017-2022)
Table Global RNA-interference (RNAi) Revenue Market Share, Region Wise (2017-2022)
Figure Global RNA-interference (RNAi) Revenue Market Share, Region Wise (2017-2022)
Figure Global RNA-interference (RNAi) Revenue Market Share, Region Wise in 2021
Table Global RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global RNA-interference (RNAi) Sales Volume by Type (2017-2022)
Table Global RNA-interference (RNAi) Sales Volume Market Share by Type (2017-2022)
Figure Global RNA-interference (RNAi) Sales Volume Market Share by Type in 2021
Table Global RNA-interference (RNAi) Revenue (Million USD) by Type (2017-2022)
Table Global RNA-interference (RNAi) Revenue Market Share by Type (2017-2022)
Figure Global RNA-interference (RNAi) Revenue Market Share by Type in 2021
Table RNA-interference (RNAi) Price by Type (2017-2022)
Figure Global RNA-interference (RNAi) Sales Volume and Growth Rate of Chemical synthesis (2017-2022)
Figure Global RNA-interference (RNAi) Revenue (Million USD) and Growth Rate of Chemical synthesis (2017-2022)
Figure Global RNA-interference (RNAi) Sales Volume and Growth Rate of In vitro transcription (2017-2022)
Figure Global RNA-interference (RNAi) Revenue (Million USD) and Growth Rate of In vitro transcription (2017-2022)
Figure Global RNA-interference (RNAi) Sales Volume and Growth Rate of In vivo expression (2017-2022)
Figure Global RNA-interference (RNAi) Revenue (Million USD) and Growth Rate of In vivo expression (2017-2022)
Table Global RNA-interference (RNAi) Consumption by Application (2017-2022)
Table Global RNA-interference (RNAi) Consumption Market Share by Application (2017-2022)
Table Global RNA-interference (RNAi) Consumption Revenue (Million USD) by Application (2017-2022)
Table Global RNA-interference (RNAi) Consumption Revenue Market Share by Application (2017-2022)
Table Global RNA-interference (RNAi) Consumption and Growth Rate of Drug Discovery and Development (2017-2022)
Table Global RNA-interference (RNAi) Consumption and Growth Rate of Therapeutics (2017-2022)
Figure Global RNA-interference (RNAi) Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global RNA-interference (RNAi) Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global RNA-interference (RNAi) Price and Trend Forecast (2022-2027)
Figure USA RNA-interference (RNAi) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe RNA-interference (RNAi) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China RNA-interference (RNAi) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan RNA-interference (RNAi) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India RNA-interference (RNAi) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia RNA-interference (RNAi) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America RNA-interference (RNAi) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa RNA-interference (RNAi) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa RNA-interference (RNAi) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global RNA-interference (RNAi) Market Sales Volume Forecast, by Type
Table Global RNA-interference (RNAi) Sales Volume Market Share Forecast, by Type
Table Global RNA-interference (RNAi) Market Revenue (Million USD) Forecast, by Type
Table Global RNA-interference (RNAi) Revenue Market Share Forecast, by Type
Table Global RNA-interference (RNAi) Price Forecast, by Type
Figure Global RNA-interference (RNAi) Revenue (Million USD) and Growth Rate of Chemical synthesis (2022-2027)
Figure Global RNA-interference (RNAi) Revenue (Million USD) and Growth Rate of Chemical synthesis (2022-2027)
Figure Global RNA-interference (RNAi) Revenue (Million USD) and Growth Rate of In vitro transcription (2022-2027)
Figure Global RNA-interference (RNAi) Revenue (Million USD) and Growth Rate of In vitro transcription (2022-2027)
Figure Global RNA-interference (RNAi) Revenue (Million USD) and Growth Rate of In vivo expression (2022-2027)
Figure Global RNA-interference (RNAi) Revenue (Million USD) and Growth Rate of In vivo expression (2022-2027)
Table Global RNA-interference (RNAi) Market Consumption Forecast, by Application
Table Global RNA-interference (RNAi) Consumption Market Share Forecast, by Application
Table Global RNA-interference (RNAi) Market Revenue (Million USD) Forecast, by Application
Table Global RNA-interference (RNAi) Revenue Market Share Forecast, by Application
Figure Global RNA-interference (RNAi) Consumption Value (Million USD) and Growth Rate of Drug Discovery and Development (2022-2027)
Figure Global RNA-interference (RNAi) Consumption Value (Million USD) and Growth Rate of Therapeutics (2022-2027)
Figure RNA-interference (RNAi) Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Tekmira Pharmaceuticals Corporation Profile
Table Tekmira Pharmaceuticals Corporation RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Tekmira Pharmaceuticals Corporation RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Tekmira Pharmaceuticals Corporation Revenue (Million USD) Market Share 2017-2022
Table Phio Pharmaceuticals Corp. Profile
Table Phio Pharmaceuticals Corp. RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Phio Pharmaceuticals Corp. RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Phio Pharmaceuticals Corp. Revenue (Million USD) Market Share 2017-2022
Table Quark Pharmaceuticals Inc. Profile
Table Quark Pharmaceuticals Inc. RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Quark Pharmaceuticals Inc. RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Quark Pharmaceuticals Inc. Revenue (Million USD) Market Share 2017-2022
Table Thermo Fisher Scientific Inc. Profile
Table Thermo Fisher Scientific Inc. RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Thermo Fisher Scientific Inc. RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Thermo Fisher Scientific Inc. Revenue (Million USD) Market Share 2017-2022
Table Ionis Pharmaceuticals Inc. Profile
Table Ionis Pharmaceuticals Inc. RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ionis Pharmaceuticals Inc. RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Ionis Pharmaceuticals Inc. Revenue (Million USD) Market Share 2017-2022
Table RXI Pharmaceuticals Profile
Table RXI Pharmaceuticals RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure RXI Pharmaceuticals RNA-interference (RNAi) Sales Volume and Growth Rate
Figure RXI Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Arcturus Therapeutics Profile
Table Arcturus Therapeutics RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Arcturus Therapeutics RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Arcturus Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Silence Therapeutics PLC Profile
Table Silence Therapeutics PLC RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Silence Therapeutics PLC RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Silence Therapeutics PLC Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Inc. (Sigma Aldrich) Profile
Table Merck & Co. Inc. (Sigma Aldrich) RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Inc. (Sigma Aldrich) RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Merck & Co. Inc. (Sigma Aldrich) Revenue (Million USD) Market Share 2017-2022
Table Dicerna Pharmaceuticals Profile
Table Dicerna Pharmaceuticals RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dicerna Pharmaceuticals RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Dicerna Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Benitec Biopharma Ltd Profile
Table Benitec Biopharma Ltd RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Benitec Biopharma Ltd RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Benitec Biopharma Ltd Revenue (Million USD) Market Share 2017-2022
Table Arrowhead Profile
Table Arrowhead RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Arrowhead RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Arrowhead Revenue (Million USD) Market Share 2017-2022
Table ISIS Pharmaceuticals Profile
Table ISIS Pharmaceuticals RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ISIS Pharmaceuticals RNA-interference (RNAi) Sales Volume and Growth Rate
Figure ISIS Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Qiagen NV Profile
Table Qiagen NV RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Qiagen NV RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Qiagen NV Revenue (Million USD) Market Share 2017-2022
Table Alnylam Pharmaceuticals Profile
Table Alnylam Pharmaceuticals RNA-interference (RNAi) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Alnylam Pharmaceuticals RNA-interference (RNAi) Sales Volume and Growth Rate
Figure Alnylam Pharmaceuticals Revenue (Million USD) Market Share 2017-2022




More Publications